Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma

• Үндсэн зохиолчид: Sandhya Pranatharthiharan (Зохиогч), Mitesh D. Patel (Зохиогч), Vinod C. Malshe (Зохиогч), Vaishali Pujari (Зохиогч), Ajit Gorakshakar (Зохиогч), Manisha Madkaikar (Зохиогч), Kanjaksha Ghosh (Зохиогч), Padma V. Devarajan (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox) nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES)-Gantrez® AN 119 Dox NPs of average size 220 nm with PDI < 0.62 and ∼20% Dox loading were prepared by modified nanoprecipitatio...